Yahoo Canada Web Search

Search results

1. • 

     How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks

     Zacks via Yahoo Finance Canada· 12 hours ago

     The traditional ways to plan for your retirement may mean income can no longer cover expenses...

2. • CBIH: Unleashing the Potential of Cannabis for Tomorrow's Medicine

     Digital Journal· 15 hours ago

     Houston, Texas--(Newsfile Corp. - July 8, 2024) - Since the start of the year, Cannabis Bioscience International Holdings (OTC Pink: CBIH) has embarked on a transformative journey involving ...

3. • 

     Eli Lilly to buy bowel disease drug developer Morphic for US$3.2-billion

     The Globe and Mail· 16 hours ago

     Eli Lilly LLY-N will acquire Morphic Holding MORF-Q for $3.2-billion in cash, the companies said on...

4. • Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal

     AOL· 17 hours ago

     (Reuters) -Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on Monday, beefing up its portfolio of inflammatory bowel disease (IBD) drugs and expanding its ...

5. • 

     The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche

     Zacks via Yahoo Finance Canada· 19 hours ago

     The NYSE ARCA Pharmaceutical Index declined 1.67% in the last five trading sessions. In the last...

6. • 

     Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics

     BioPharma-Reporter· 4 days ago

     Consequently commercial demands of many of these next generation therapeutics are lower, ranging...

7. • 

     2 Boston Partners Mutual Funds for Maximum Returns

     Zacks via Yahoo Finance Canada· 4 days ago

     Ramallo has been the lead manager of BPAVX since Dec 30, 2007. Most of the fund’s holdings were in companies like Johnson & Johnson (2.2%), JPMorgan...

8. • AbbVie cuts 2024 profit forecast on R&D expenses

     StreetInsider· 5 days ago

     (Reuters) -AbbVie lowered its 2024 adjusted profit forecast on Wednesday, citing $937 million in milestones, and research and development expenses related to acquisitions.

9. • 

     Drug companies challenge Minnesota prescription discount law in federal court

     MPR News· 5 days ago

     Several drug companies filed lawsuits in federal court this week challenging a Minnesota law...

10. • News By Company | Zymeworks Inc. News on T-Net

      T-Net British Columbia· 5 days ago

      Zymeworks